Results 141 to 150 of about 29,486 (214)

Spike-Specific Memory B Cell Response in Hematopoietic Cell Transplantation Recipients following Multiple mRNA-1273 Vaccinations: A Longitudinal Observational Study [PDF]

Elena Pettini, Annalisa Ciabattini, Fabio Fiorino, Jacopo Polvere, G Pastore, Monica Tozzi, Francesca Montagnani, Giuseppe Marotta, Alessandro Bucalossi, Donata Medaglini   +9 more
openalex   +1 more source

Comments on “Serological response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 prime-boost vaccination”

, 2022
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit   +1 more
openalex   +1 more source

Waning of two-dose BNT162b2 and mRNA-1273 vaccine effectiveness against symptomatic SARS-CoV-2 infection is robust to depletion-of-susceptibles bias [PDF]

, 2022
Kristin L. Andrejko, Jake M. Pry, Jennifer F. Myers, Megha Mehrotra, Katherine Lamba, Esther Lim, Nozomi Fukui, Jennifer L. DeGuzman, John J. Openshaw, James Watt, Seema Jain, Joseph A. Lewnard   +11 more
openalex   +1 more source

Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines

, 2022
Natalia Abraham, Sarah Spruin, Tanya Rossi, Bruce Fireman, Joseline Zafack, Christine Blaser, Amanda Shaw, Kimberley Hutchings, Susanna Ogunnaike-Cooke   +8 more
openalex   +1 more source

Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273 [PDF]

, 2021
Deborah Steensels, Noëlla Pierlet, Joris Penders, Dieter Mesotten, Line Heylen   +4 more
openalex   +1 more source

Safety and immunogenicity of homologous versus heterologous booster dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-CoV-2 vaccines in adults: An observer-blinded, multi-center, phase 2 randomized trial

, 2023
Lila Estephan, Ying‐Chin Lin, Yi‐Tsung Lin, Yen‐Hsu Chen, Sung‐Ching Pan, Szu‐Min Hsieh, Paal Fure Torkehagen, Yi-Jen Weng, Hao‐Yuan Cheng, Josue Antonio Estrada, Alexander Waits, Charles Chen, Chia-En Lien   +12 more
openalex   +1 more source

Signatures of Trained Immunity Following mRNA Vaccination: Differences Between mRNA-1273 and BNT162b2. [PDF]

J Clin Immunol
Kunc M, Whitehead BJ, Østergaard LJ, Tolstrup M, Benn CS, Wejse CM, Nejsum P.   +6 more
europepmc   +1 more source

Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial

, 2022
Hana M. El Sahly, Lindsey R. Baden, Brandon Essink, David C. Montefiori, Adrian McDermont, Richard Rupp, Michael Lewis, Shobha Swaminathan, Carl Griffin, Veronica Fragoso, Vicki E. Miller, Bethany Girard, Yamuna Devi Paila, Weiping Deng, Joanne E. Tomassini, Robert Paris, F. Schödel, Rituparna Das, Allison August, Brett Leav, Jacqueline M. Miller, Honghong Zhou, Rolando Pajón, for the Coronavirus Efficacy (COVE) Study Group   +23 more
openalex   +2 more sources

Evaluation of Cardiac Troponin Levels in Individuals Aged 12-30 Years Following mRNA-1273 Vaccination: Results From a Randomized Placebo-Controlled Trial. [PDF]

Open Forum Infect Dis
Pfeiffer S, Rhee M, Striplin S, Urdaneta V, Straus W, Wang X, Girard B, Priddy F, Chalkias S.   +8 more
europepmc   +1 more source

IgG4 Neutralization and Sustained Total IgG Fc-Effector Functions Following Repeated SARS-CoV-2 Vaccination with mRNA-1273. [PDF]

Infect Dis Ther
Kaplonek P, Bertera H, Lee DW, Cizmeci D, Yu WH, Wu K, Chalkias S, Wahid R, Edwards D, Alter G, Henry C.   +10 more
europepmc   +1 more source